Objective: To determine the incidence, duration and cause of hospitalization in a cohort of Danish patients with systemic lupus erythematosus (SLE). In addition, we investigated risk factors for admission and prolonged hospital stay. Methods: A total of 155 SLE patients from a population-based cohort were included in the study during a period of 70 months, from January 2007 to October 2012. Data on frequency, cause and duration of hospitalizations were obtained by review of medical charts. Data on disease manifestations, organ damage and treatment were collected prospectively. Results: A total of 101 of the 155 SLE patients (65%) had one or more hospitalization during the study period. The incidence rate of all hospitalizations was 0.50 per year. Leading causes of admission were complications to SLE or its treatment, but infections were also common. Mean duration of hospital stay was 6.4 AE 10.5 days, and SLE Disease Activity Index 2000 (SLEDAI-2K) on admission emerged as a risk factor for prolonged hospital stay. Conclusion: Danish SLE patients experience frequent admissions to hospital. Complications to SLE or its treatment, as well as infections, are leading causes of admission. High SLEDAI-2K on admission is a risk factor for prolonged hospital stay. Lupus (2018) 27, 165-171.
Introduction
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by protean clinical manifestations often with a relapsing, remitting pattern. 1, 2 SLE is potentially lethal, but SLE mortality has declined significantly over the past decades from a 5-year survival below 50% to now over 90%. 3, 4 Still, SLE is associated with excess mortality and morbidity requiring more frequent hospital admissions compared to the general population. 5 Direct and indirect healthcare costs per SLE patient are considerable primarily due to active disease and concomitant morbidities. 6 Due to longer life expectancy SLE patients experience increasing cumulative organ damage and this has become an important clinical issue. 7 Studies on hospitalization rates in patients with SLE have yielded significant differences regarding frequencies of hospitalization. Thus, hospitalization frequencies range between 8.6% and 18.9% per year to as high as 56% in 2 years. 5, 8 A cohort study from Singapore reported that 13.1% of patients were hospitalized at least once during 1-year surveillance and a Canadian study found annual hospitalization rates of 22% and 28%.
common. 5, 8, 9, [11] [12] [13] [14] [15] [16] [17] Inter-study differences on hospitalizations may reflect distinctive local disease profiles, but may also reflect the impact of different healthcare systems and variable clinical practice. Hospitalization patterns have not previously been reported in a Scandinavian setting, where healthcare systems are almost exclusively funded by the public social security including all citizens.
The aims of this study were to determine the annual incidence, causes and outcome of hospitalizations in SLE patients from a Danish populationbased cohort. Furthermore, we wanted to identify risk factors for hospitalization and for prolonged hospital stays.
Materials and methods

Study population
The study population consisted of all SLE patients from a population-based cohort followed prospectively since 1995, with inclusion of incident and immigrated patients during surveillance. 2, 18 All patients were diagnosed according to Fries and Holman 19 and classified according to the 1997 revised American College of Rheumatology (ACR) criteria. 20 All patients were offered specialized and free care in a dedicated lupus outpatient clinic at 1-4 months intervals as needed.
Data collection
Data on disease manifestations, organ damage (Systemic Lupus International Collaborating Clinics/ACR damage index (SDI)), 21, 22 hospitalizations between January 2007 and October 2012, and medical treatment have been registered prospectively. The primary causes of hospitalization were categorized as follows: SLE disease activity (i.e. clinical and biochemical manifestations typically seen in SLE); infection (i.e. clinical picture supported by biochemical and imaging findings); complications to SLE or its treatment and other (medical and surgical). Complications to SLE or its treatment included cardiovascular disease, renal insufficiency comprising e.g. establishing and maintaining dialysis, adverse effects of medical treatment including osteoporosis and diabetes, pregnancy-related morbidity including missed abortions, and degenerative musculoskeletal conditions. In the subgroup called 'other, medical' contacts included activity in comorbid diseases, e.g. Crohn's disease and chronic pancreatitis, whereas 'other, surgical' included cancer, gynaecological disease, bile duct surgery and joint replacement.
The primary cause of death was registered in deceased patients.
In order to identify risk factors for prolonged hospitalization, medical records covering all admissions at the Department of Rheumatology, Odense University Hospital, were scrutinized and biochemical data at admission were registered: blood haemoglobin, plasma albumin and C-reactive protein (CRP). Ongoing renal involvement defined as proteinuria greater than 0.5 g/day or greater than 3þ, glomerular filtration rate less than 50%, endstage nephropathy or lupus nephritis diagnosed by kidney biopsy was also registered. Disease activity at admission was determined by means of the Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K). 22 The study project was approved by the local ethics committee and the Danish Data Protection Agency ID 20100015.
Statistical analysis
Continuous variables are presented as mean (AE standard deviation (SD)) or median (range), and categorical variables are given as frequencies and percentages. Student's t-test (Gaussian distributed data) and Wilcoxon rank-sum test (non-Gaussian distributed data) were used for continuous variables, and the 2 test was used for categorical variables. Crude annual hospitalization rate is calculated as the percentage of patients hospitalized once or more per calendar year. The incidence rate of the first admission was calculated by counting time at risk starting as of 1 January 2007, date of immigration or at the date of diagnosis, whichever came first. Time at risk ended on the day of first admission, date of emigration or death or 31 October 2012, whichever came first.
The relationship between the number of hospitalizations and SDI was assessed by Spearman correlation. In order to define potential explanatory variables for prolonged hospitalization, defined as 7 days or more, clinical variables were included in a multivariate logistic regression model, in which stepwise backwards elimination was applied for adjustment. P values less than 0.05 were considered statistically significant in the regression model. The analysis was performed using STATA 13.1.
Results
As of 1 January 2007, 131 prevalent patients were registered and during 70 months of follow-up 24 incident/immigrated SLE patients were included. In total, 155 patients participated in the study.
During the study period 101 patients (65%) had one or more hospitalizations amounting to a total of 446; 122 of the 446 admissions took place in the Department of Rheumatology at Odense University Hospital. Additional admissions included general internal medicine, nephrology, infectious disease, cardiology, gynaecology and obstetrics.
The crude annual hospitalization rate was 25%, with annual rates of 32% (43/ Male patients had significantly more admissions than women, median four (range 1-28) versus two (range 1-27), P ¼ 0.02. Men tended to be older at first admission compared to women, 52.5 AE 13.2 years versus 46.3 AE 16.5 years, P ¼ 0.069.
The characteristics of SLE patients with one or more admissions compared to those without admissions are shown in Table 1 . At the end of follow-up patients admitted versus those not admitted tended to be younger of age, while the mean disease duration did not differ (Table 1) . Prednisolone had been prescribed significantly more often to patients admitted to hospital than to those not admitted, 94% versus 78%, P < 0.01. Hospitalized patients did not differ from those not admitted regarding the use of hydroxychloroquine, the presence of antiphospholipid syndrome, lupus nephritis or smoking habits (Table 1) .
SLE patients admitted to hospital had significantly higher cumulated SDI at the end of the study period than those not admitted, 2 (0-11) versus 1 (0-5), P ¼ 0.04. The number of hospitalizations experienced by each patient correlated with SDI at the end of the study period as shown in Figure 1 .
The most frequent cause of hospitalization was complications to SLE or its treatment comprising 140 out of 446 hospitalizations (31%). Other frequent causes were infections and SLE disease activity accounting for 21% and 15% of hospitalizations, respectively ( Table 2) .
Cardiovascular disease was the most common cause of hospitalization within the group of 'complications to SLE or its treatment', including ischaemic heart disease and cardiac valvulopathy. In particular, nine patients had 15 admissions due to coronary artery disease despite a median age of 51 years (39-76). Renal insufficiency, including establishing and maintaining dialysis, was the cause of 36 hospital admissions among only six patients. Adverse effects to medical treatment of SLE comprise frequent admissions, mainly due to confirmed or suspected adrenal insufficiency (Table 2) . Other medical and surgical causes were unrelated to SLE including labour and cancer surgery. During the observation period 35% of patients were admitted once or more due to SLE disease activity and 45% due to infection.
Mean disease duration on the day of first admission differed according to the cause of admission. The first admission due to SLE disease activity took place after a mean disease duration of 7.5 (AE8.2) years, admission due to infection at 12.8 (AE10.5) years and admission due to complications to SLE or its treatment after 14.9 (AE8.7) years. Disease duration was significantly shorter among admissions due to SLE disease activity compared to the group of complications to SLE or its treatment, P ¼ 0.003, and compared to infections, P ¼ 0.017.
Most of the 446 hospitalizations (91%) were followed by an unaltered cumulative damage score (SDI), but increasing SDI was found in 9% of the hospitalizations. Four patients died (1%), two women and two men. Causes of death were pneumonia, perforation of gastric ulcer, acute myeloid leukaemia and pulmonary embolism. In only three of all admissions the patients (all women) were managed in the intensive care unit (ICU). Increasing SDI was noted in all of these. Hospital The mean duration of hospitalization was 6.4 AE 10.5 days, 22% of the hospital stays lasted one day. Calculation of the risk for a prolonged hospital stay, defined as 7 days or more, showed that SLE disease activity measured as SLEDAI-2K (odds ratio (OR) 1.08, 95% confidence interval (CI) 1.00-1.17, P ¼ 0.038) on admission emerged as a significant risk factor for prolonged hospital stays (Table 3) .
Discussion
In a population-based Danish SLE cohort, the mean annual hospitalization rate was 25%. SLE patients admitted to hospital were younger of age and more frequently treated with prednisolone than those not admitted. There was a positive correlation of admissions per patient and higher SDI at the end of the study. Active SLE as assessed by SLEDAI-2K emerged as a risk factor for prolonged hospital stay.
An average hospitalization rate of 25% is in accordance with that reported in a North American study, 10 but is higher than in several other studies with hospitalization rates ranging from 8.6% to 28% annually. [8] [9] [10] Possible explanations to these discrepancies may be different clinical manifestations of SLE in populations of different ethnicity. Thus, there is robust evidence of a higher prevalence of SLE in populations of black, Asian and Hispanic ancestry, as compared to Caucasians. Furthermore, black, Asian and Hispanic SLE patients have more severe courses and accumulate damage at earlier stages of the disease than Caucasian SLE patients. 23 The present predominantly Caucasian study population is Figure 1 Correlation between number of hospitalizations and damage score at the end of the study measured by SDI. Therefore, our finding of relatively high hospitalization rates with many short-lasting admissions at non-rheumatological departments may reflect different local practice. Thus, it could be speculated that non-rheumatological experts tend to hospitalize SLE patients more frequently due to the well-known difficulty of managing an unpredictable disease. Furthermore, it might be of importance that in Denmark healthcare, including admission, is free of charge, whereas in other countries this is sometimes based on private insurance. The incidence rate of all admissions of 0.50 per year at risk in our cohort is comparable to an average incidence rate of 0.687 reported in an American clinic-based lupus cohort. 5 A lower incidence might have been expected in the present study, as our cohort is population based with unselected patients including also milder courses of SLE. 4 Finding that Danish SLE patients admitted once or more had higher damage scores at the end of the observation period is in accordance with a Canadian report on an increased number of admissions among patients with damage. 24 The finding that admitted patients were more often on corticosteroids is in accordance with findings in the Hopkins Lupus Cohort in which prednisolone use and the use of immunosuppressive drugs are reported to be predictors of hospitalization due to infection. 5 In our study, 88% of patients were treated with prednisolone. Thus, in addition to the wellknown side-effects of glucocorticoids, evidence is emerging that patients on prednisolone experience increased damage accrual independent of disease activity, increased cardiovascular morbidity in particular, with evidence of a dose-dependent effect, but without an established safe dose. 25 This new insight has resulted in the treat-to-target in systemic lupus erythematosus recommendations, which among other things advise maintenance treatment with glucocorticoids to be reduced, and whenever possible to withdraw from these agents. 26 The finding that patients of younger age tended to be admitted more frequently has not been observed in previous studies, whereas age has been found to be related to the disease course. One study on an inception cohort found that patients diagnosed with SLE above the age of 25 years had a longer clinically quiescent period than patients diagnosed at a younger age. 27 Another study from our group demonstrated that patients with disease flares had shorter disease duration and were younger at the time of diagnosis than patients with a quiescent course. 2 This accords with a Canadian study in which patients admitted due to active SLE were significantly younger and had a shorter disease duration.
In the present study, admitted SLE patients had significantly higher SDI than those not admitted. This emphasizes that hospitalization is a risk marker for disease progression in SLE, implying a need for careful surveillance and treatment. 26 Male SLE patients had more admissions than women, which supports the suggestion that male gender is an independent risk factor for an adverse outcome including increased mortality and more frequent transfer to ICUs. 7, 28 Male SLE patients were slightly older than women when admitted, but age alone probably does not account for the increased number of admissions. The age difference is likely to mirror previous reports that male patients tend to be older than female patients at diagnosis of SLE. 3 The finding that only 122 of 446 admissions (27%) took place in the Department of Rheumatology may reflect the involvement of multiple organ systems in SLE, and of the increasing impact of damage due to SLE, as patients live longer possibly creating a greater need for consulting other medical specialties. 7 The many nonrheumatological hospitalizations may also reflect a lower threshold for admission in other medical specialties. Therefore, it should be considered if it is appropriate that many admissions take place in non-rheumatological departments, not least in view of SLE patients' risk of hospital-acquired infections and the economic consequences for society. These issues were investigated in an American study finding a substantial financial burden due to hospitalizations of patients with SLE. 6 Thus, it can be argued that the management of SLE patients should primarily take place on an outpatient basis and that hospitalizations should occur in a rheumatological department taking responsibility for coordination of the admission course. An Italian study reported that the number of admissions caused by SLE as a primary cause was halved during the study period of 12 years despite increasing numbers of patients, possibly because of better treatment and good outpatient management. 29 In Denmark, as well as other European countries, the trend of healthcare is shifting from predominantly inpatient to outpatient treatment, 30 and this could be beneficial for SLE patients as well.
Active SLE is a common cause of admission comprising 15% in our study, which is in accordance with 17.5% in a recent Canadian study. 8 Other investigations have reported SLE activity as the leading cause of admission at 11-80.8%, probably reflecting different clinical practice as well as different trial designs. 12, 13, 17, 24 Infection was the cause of hospitalization in 21% of the cases. A similar proportion was reported in the Canadian study. 8 A study on hospitalized SLE patients also found infections to be common, in that one third of the patients developed infections during hospitalization 15 and of note, SLEDAI-2K was a significant predictor for the development of infection during admission.
Cardiovascular causes of hospitalization were common, including several cases of coronary artery disease. Even young individuals experienced manifestations of atherosclerosis, which has emerged as a significant comorbidity in this group of patients within the past few years. 31, 32 Death occurred in 1% of the hospitalizations, which is lower than in previous studies in which a deadly outcome amounted to 2.8-9% of admissions. 8, 9, [11] [12] [13] [14] 17, 24, 28 Increased SLEDAI-2K at admission was a significant risk factor for prolonged hospital stays. A recent study on non-SLE-related admissions among SLE patients did not find SLEDAI-2K prognostic for the outcome of hospitalizations regarding duration, transfer to an ICU or readmission, suggesting that other specific SLE pathways are important for these outcomes. 28 Anaemia and kidney involvement are well-defined predictors of an adverse outcome, 1, 33 but in the present study we could not confirm this association. This may relate to the limited number of patients under investigation.
A limitation to this study is that the study population of 155 individuals is relatively small for the investigation of outcome and risk factors. Furthermore, data about risk factors at the day of admission, including SLEDAI-2K, were collected retrospectively leaving some uncertainty to data.
The strength of the study is the population-based approach and the high participation among the SLE patients in the region. 18 The fact that the study covers all hospitals in the region and that Danish inhabitants have access to public hospital care free of charge adds to the completeness of the data. Our study includes all causes of hospitalizations regardless of department. There are only a few previous studies of hospitalizations among cohorts of SLE patients followed prospectively. 5 In conclusion, this study shows a high incidence rate of hospital admissions during a 70-month follow-up of a population-based SLE cohort. Hospitalized patients were significantly younger and received prednisolone more often than patients who were not admitted. Complications to SLE or its treatment, including cardiovascular comorbidity and renal insufficiency, was the most frequent cause of admission. Other common causes were SLE disease activity as well as infections. SDI was unchanged after most admissions and mortality in relation to hospitalization was low. Patients with elevated SLEDAI-2K on admission had longer hospital stays.
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